ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, Ph.D. will present at the 2011 World Stem Cell Summit in Pasadena, California at 2:30 p.m. PDT on Monday, October 3, 2011. Dr. West will be presenting “Unleashing Regenerative Medicine to Extend the Healthy Lifespan: Technological Issues and Commercial Opportunities” which will include a discussion for the first time of BioTime's novel vascular and muscle progenitor cell lines created using the Company's proprietary ACTCellerate™ technology. The presentation will be made available on BioTime's web site www.biotimeinc.com.